CSL (ASX:CSL) appoints Paul McKenzie to lead company
CSL (CSL) appoints Paul McKenzie as its new Chief Executive Officer and…
Csl Limited (ASX:CSL)
About Csl Limited
Key Information
CSL In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 23/04/2024 | Shareholder Information Meetings | 1.91MB | 736 |
| 11/04/2024 | CSL Australia Investor Site Tour Presentations | 6.82MB | 3.6K |
| 08/04/2024 | Publication of AEGIS II Trial Data | 148.58KB | 447 |
| 05/04/2024 | Notification of cessation of securities - CSL | 12.65KB | 239 |
| 27/03/2024 | CSL prices US$1.25 billion in Corporate Bonds | 156.07KB | 537 |
| 19/03/2024 | Change in substantial holding | 2.14MB | 391 |
| 14/03/2024 | Update - Dividend/Distribution - CSL | 16KB | 619 |
| 08/03/2024 | Application for quotation of securities - CSL | 17.12KB | 340 |
Share Price History
Officers & Directors
Insider Transactions
Frequently Asked Questions
|
What ASX sector is CSL?
CSL belongs to the Biotechnology sector. Their Principal Activity is the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
|
|
When did CSL list on the ASX?
CSL has been listed on the ASX since 1994, following its conversion to a public company 100% owned by the Federal Government in 1991.
|
|
Where is CSL based?
CSL's head office is located in Melbourne, Australia, offering products and services globally.
|